{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:27:38Z","timestamp":1793755658694,"version":"4.6.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10815-026-03934-x","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:28:57Z","timestamp":1782178137000},"page":"2829-2843","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cost-effectiveness of infertility treatment pathways in PCOS: where does oocyte in-vitro maturation fit?"],"prefix":"10.1007","volume":"43","author":[{"given":"Linde","family":"Mostinckx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neli","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Lelie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari","family":"Mackens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Segers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Beeckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"6","key":"3934_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/humupd\/dmw025","volume":"22","author":"AH Balen","year":"2016","unstructured":"Balen AH, Morley LC, Misso M, Franks S, Legro RS, Chandrika N, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22(6):687\u2013708. https:\/\/doi.org\/10.1093\/humupd\/dmw025.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"3934_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001122.pub5","volume":"2","author":"EM Bordewijk","year":"2020","unstructured":"Bordewijk EM, Ng KYB, Rakic L, Mol BWJ, Brown J, Crawford TJ, et al. Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev. 2020;2(2):CD001122. https:\/\/doi.org\/10.1002\/14651858.CD001122.pub5.","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"3934_CR3","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841\u201355. https:\/\/doi.org\/10.1093\/humrep\/dew218.","journal-title":"Hum Reprod"},{"issue":"1","key":"3934_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.rbmo.2020.09.022","volume":"42","author":"SC Braam","year":"2021","unstructured":"Braam SC, Ho VNA, Pham TD, Mol BW, van Wely M, Vuong LN. In-vitro maturation versus IVF: a cost-effectiveness analysis. Reprod Biomed Online. 2021;42(1):143\u20139. https:\/\/doi.org\/10.1016\/j.rbmo.2020.09.022.","journal-title":"Reprod Biomed Online"},{"key":"3934_CR5","first-page":"1","volume":"89","author":"A Fenwick","year":"2023","unstructured":"Fenwick A, Eze A, D\u2019Hooghe T, Pandey S, Chaudhari VS, Ostawal A, et al. The value of treatment for infertility: a systematic literature review of willingness-to-pay thresholds and approaches for determining the cost effectiveness of fertility treatment. Clin Obstet Gynecol. 2023;89:1\u201322.","journal-title":"Clin Obstet Gynecol"},{"issue":"9","key":"3934_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010287.pub4","volume":"9","author":"S Franik","year":"2022","unstructured":"Franik S, Le Q, Kremer JA, Kiesel L, Farquhar C. Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2022;9(9):CD010287. https:\/\/doi.org\/10.1002\/14651858.CD010287.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"3934_CR7","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S1472-6483(10)61632-X","volume":"9","author":"S Gerli","year":"2004","unstructured":"Gerli S, Casini ML, Unfer V, Costabile L, Mignosa M, Di Renzo GC. Ovulation induction with urinary FSH or recombinant FSH in polycystic ovary syndrome patients: a prospective randomized analysis of cost-effectiveness. Reprod Biomed Online. 2004;9(5):494\u20139. https:\/\/doi.org\/10.1016\/S1472-6483(10)61632-X.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"3934_CR8","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/humrep\/der401","volume":"27","author":"R Homburg","year":"2011","unstructured":"Homburg R, Hendriks ML, K\u00f6nig TE, Anderson RA, Balen AH, Brincat M, et al. Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study. Hum Reprod. 2011;27(2):468\u201373. https:\/\/doi.org\/10.1093\/humrep\/der401.","journal-title":"Hum Reprod"},{"issue":"2","key":"3934_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1055\/s-0035-1571195","volume":"34","author":"AE Joham","year":"2016","unstructured":"Joham AE, Palomba S, Hart R. Polycystic ovary syndrome, obesity and pregnancy. Semin Reprod Med. 2016;34(2):93\u2013101. https:\/\/doi.org\/10.1055\/s-0035-1571195.","journal-title":"Semin Reprod Med"},{"issue":"1","key":"3934_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40258-022-00764-7","volume":"21","author":"E Keller","year":"2022","unstructured":"Keller E, Botha W, Chamber GM. What features of fertility treatment do patients value? Price elasticity and willingness-to-pay values from a discrete choice experiment. Appl Health Econ Health Policy. 2022;21(1):91\u2013107.","journal-title":"Appl Health Econ Health Policy"},{"issue":"3","key":"3934_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/humrep\/deu299","volume":"30","author":"AM Kolte","year":"2015","unstructured":"Kolte AM, Bernardi LA, Christiansen OB, Quenby S, Farquharson RG, Goddijn M, et al. ESHRE Special Interest Group, Early Pregnancy. Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod. 2015;30(3):495\u20138.","journal-title":"Hum Reprod"},{"key":"3934_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007506.pub4","author":"SS Lim","year":"2019","unstructured":"Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2019. https:\/\/doi.org\/10.1002\/14651858.CD007506.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"3934_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/humrep\/dead241","volume":"39","author":"X Liu","year":"2024","unstructured":"Liu X, Zhang J, Wang S. Global, regional, and national burden of infertility attributable to PCOS, 1990\u20132019. Hum Reprod. 2024;39(1):108\u201318. https:\/\/doi.org\/10.1093\/humrep\/dead241.","journal-title":"Hum Reprod"},{"issue":"3","key":"3934_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.rbmo.2021.11.009","volume":"44","author":"S Mackens","year":"2022","unstructured":"Mackens S, Drakopoulos P, Moeykens MF, Mostinckx L, Boudry L, Segers I, et al. Cumulative live birth rate after ovarian stimulation with freeze-all in women with polycystic ovaries: does the polycystic ovary syndrome phenotype have an impact? Reprod Biomed Online. 2022;44(3):565\u201371.","journal-title":"Reprod Biomed Online"},{"key":"3934_CR15","doi-asserted-by":"publisher","unstructured":"Macklon NS, Fauser BCJM. Gonadotropins in ovulation induction. Reprod Biomed Online 2005;10:25\u201331. https:\/\/doi.org\/10.1016\/S1472-6483(11)60387-8.","DOI":"10.1016\/S1472-6483(11)60387-8"},{"issue":"5","key":"3934_CR16","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.rbmo.2014.01.014","volume":"28","author":"LM Moolenaar","year":"2014","unstructured":"Moolenaar LM, Nahuis MJ, Hompres PG, van der Veen F, Mol BWJ. Cost-effectiveness of treatment strategies in women with PCOS who do not conceive after six cycles of clomiphene citrate. Reprod Biomed Online. 2014;28(5):606\u201313. https:\/\/doi.org\/10.1016\/j.rbmo.2014.01.014.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"3934_CR17","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.fertnstert.2023.11.008","volume":"121","author":"KM Moss","year":"2024","unstructured":"Moss KM, Doust J, Copp T, Homer H, Misha GD. Fertility treatment pathways and births for women with and without polycystic ovary syndrome\u2014a retrospective population linked data study. Fertil Steril. 2024;121(2):314\u201322.","journal-title":"Fertil Steril"},{"issue":"3","key":"3934_CR18","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/humrep\/dead273","volume":"39","author":"L Mostinckx","year":"2024","unstructured":"Mostinckx L, Goyens E, Mackens S, Roelens C, Boudry L, Uvin V, et al. Clinical outcomes from ART in predicted hyperresponders: in vitro maturation of oocytes versus conventional ovarian stimulation for IVF\/ICSI. Hum Reprod. 2024;39(3):586\u201394.","journal-title":"Hum Reprod"},{"issue":"9","key":"3934_CR19","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/humrep\/dez086","volume":"34","author":"L Mostinckx","year":"2019","unstructured":"Mostinckx L, Segers I, Belva F, Buyl R, Santos-Ribeiro S, Blockeel C, et al. Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation. Hum Reprod. 2019;34(9):1595\u2013607.","journal-title":"Hum Reprod"},{"key":"3934_CR20","unstructured":"Practice committees of the American Society for Reproductive Medicine, The Society of Reproductive Biologists and Technologists, and the Society for Assisted Reproductive Technology. Fertil Steril 2021;115:298\u2013304"},{"issue":"1","key":"3934_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137. https:\/\/doi.org\/10.1093\/humrep\/deh098.","journal-title":"Hum Reprod"},{"issue":"9","key":"3934_CR22","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1093\/humrep\/deaa226","volume":"35","author":"S Santos-Ribeiro","year":"2020","unstructured":"Santos-Ribeiro S, Mackens S, Popovic-Todorovic B, Racca A, Polyzos NP, Van Landuyt L, et al. The freeze-all strategy versus agonist triggering with low-dose hCG for luteal phase support in IVF\/ICSI for high responders: a randomized controlled trial. Hum Reprod. 2020;35(9):2808\u201318. https:\/\/doi.org\/10.1093\/humrep\/deaa226.","journal-title":"Hum Reprod"},{"key":"3934_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/ajmg.1320350205","volume":"35","author":"JL Simpson","year":"1990","unstructured":"Simpson JL. Incidence and timing of pregnancy losses: relevance to evaluating safety of early prenatal diagnosis. Am J Med Genet. 1990;35:165\u201373.","journal-title":"Am J Med Genet"},{"issue":"9","key":"3934_CR24","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/humrep\/dead156","volume":"38","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CH, Laven J, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Hum Reprod. 2023;38(9):1655\u201379. https:\/\/doi.org\/10.1093\/humrep\/dead156.","journal-title":"Hum Reprod"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-026-03934-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-026-03934-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-026-03934-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:05:10Z","timestamp":1793754310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-026-03934-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3934"],"URL":"https:\/\/doi.org\/10.1007\/s10815-026-03934-x","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised. The author note was missing from this article and should have read: \"Linde Mostinckx and Neli Hofer contributed equally to this work and share first authorship.\"","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethical Committee of the Universitair Ziekenhuis Brussel, reference number EC-2024-073, in February 2024.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript has been read and approved for submission by all the named authors.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.D.V. declares honoraria for lecturing from Ferring, Gedeon Richter, Organon, Roche and IBSA in the past 2\u00a0years. M.D.V. is a member of the scientific advisory board of Gameto Inc. All other authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}